SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001104659-24-073631
Filing Date
2024-06-20
Accepted
2024-06-20 21:38:51
Documents
1
Period of Report
2024-06-18

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT tm2417588-1_4seq1.html 4  
1 OWNERSHIP DOCUMENT tm2417588-1_4seq1.xml 4 6628
  Complete submission text file 0001104659-24-073631.txt   8221
Mailing Address VERTEX PHARMACEUTICALS INCORPORATED 130 WAVERLY ST. CAMBRIDGE MA 02139
Business Address
Arbuckle Stuart A (Reporting) CIK: 0001557290 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38223 | Film No.: 241058232

Mailing Address 222 BERKELEY STREET 12TH FLOOR BOSTON MA 02116
Business Address 222 BERKELEY STREET 12TH FLOOR BOSTON MA 02116 857-264-4280
RHYTHM PHARMACEUTICALS, INC. (Issuer) CIK: 0001649904 (see all company filings)

IRS No.: 462159271 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)